RSS

opioids

Tatsiana Levdikova, content marketer at OpenLedger ApS, a blockchain development company, writes about the opioid epidemic in the US and if blockchain is the answer. Read more

Opinion

Pharmaceutical company Camurus explains how the company’s latest technology aims to improve clinical outcomes and potentially reduce opioid dependence. Read more

Technology

Biopharma services provider PCI Pharma (PCI) is investing further in its infrastructure for packaging of controlled substances, the company has announced. Read more

News

The US Food and Drug Administration (FDA) has approved new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence. Read more

News

The US Food and Drug Administration (FDA) has issued warnings to four more online networks (operating a total of 21 websites) concerning the illegal marketing of potentially dangerous, unapproved and misbranded versions of opioid medications. Read more

News

New research from UCL, the University of Sheffield and the Hospital for Sick Children, Toronto, has highlighted that a modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects Read more

News

The MedTalk Podcast returns with its first episode of 2018, looking at the biggest and most topical news of the year so far in the digital health, pharma, medical plastics and med-tech spaces. Read more

Opinion

The US Food and Drug Administration (FDA) has issued a safety communication concerning the limitation of packaging for anti-diarrhoea medicine, loperamide, as a result of product misuse and abuse. Read more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

The University of Warwick has announced the commencement of a trial that is aiming to improve long-term painkiller users’ lives and reduce their dependency on the drugs. Read more

News

Researchers from the University of Akron, Ohio, have developed a device made from a degradable polymer mesh that may assist in the fight against the opioid epidemic. Read more

Technology

The US Food and Drug Administration (FDA) has granted marketing authorisation to an electric stimulation device aimed at helping to reduce the symptoms associated with opioid withdrawal. Read more

Technology

The advisory committee of the US Food and Drug Administration (FDA) has recommended the approval of Braeburn Pharmaceutical’s investigational buprenorphine depot, CAM2038, for the treatment of opioid use disorder. Read more

News

A drug delivery device that has been patented by the US Patent & Trademark Office and will be submitted for marketing clearance by the Food and Drug Administration (FDA) offers overdose prevention in prescription opioids. Read more

Technology

It will come as no surprise that the new chief of the FDA faces a raft of issues as he takes on his new role. Read more

News

Lucideon and Skyepharma sign an exclusive feasibility, development and licence agreement to provide Skyepharma’s oral business with access to Lucideon’s proprietary abuse deterrent controlled release technology, iCRT-deter Read more

News

The Psychopharmacologic Drugs Advisory Committee (PDAC) of the US Food and Drug Administration (FDA) has voted in favour of approving Probuphine, an implant to treat opioid addiction Read more

News

The trial successfully met its primary efficacy endpoint in demonstrating that BEMA buprenorphine resulted in significantly improved chronic pain relief compared to placebo. Read more

CPhI Worldwide is an excellent convention for meeting pharmaceutical industry professionals from all over the world in one location and the Rhodes Technologies team is looking forward to meeting friends and colleagues there. Read more

News